Centrosomes are the major microtubule-organizing centers in animal cells and regulate formation of a bipolar mitotic spindle. Aberrant centrosome number causes chromosome mis-segregation, and has been implicated in genomic instability and tumor development. Previous studies have demonstrated a role for the DNA replication factors MCM5 and Orc1 in preventing centrosome reduplication. Cyclin A-Cdk2 localizes on centrosomes by means of a modular centrosomal localization sequence (CLS) that is distinct from that of cyclin E. Here, we show that cyclin A interacts with both MCM5 and Orc1 in a CLS-dependent but Cdk-independent manner. Although the MRAIL hydrophobic patch is contained within the cyclin A CLS, binding of both MCM5 and Orc1 to cyclin A does not require a wild-type hydrophobic patch. The same domain in MCM5 that mediates interaction with cyclin E also binds cyclin A, resulting in centrosomal localization of MCM5. Finally, unlike its function in DNA synthesis, MCM5-mediated inhibition of centrosome reduplication in S-phase-arrested CHO cells does not require binding to other MCM family members. These results suggest that cyclins E and A sequentially prevent centrosome reduplication throughout interphase by recruitment of DNA replication factors such as MCM5 and Orc1.
Introduction
As the major microtubule-organizing centers in animal cells, centrosomes dictate the bipolarity of the mitotic spindle that is essential for ensuring equal segregation of chromosomal DNA between two daughter cells. Centrosome amplification has been reported in virtually all types of solid tumors and is an underlying cause of aneuploidy, probably contributing to the development and progression of human cancers (Fukasawa, 2005; Ganem et al., 2009; Lingle et al., 2005) . Centrosome duplication and DNA replication are fundamentally similar in that both undergo onceand-only-once semi-conservative duplication during every cell cycle. Both duplication events are initiated near the G1-S boundary and are coupled by increased cyclin-dependent kinase 2 (Cdk2) activity. Many groups have provided evidence that increased Cdk2 activity in late G1 is essential for these events, as inhibition of Cdk activity in either Xenopus egg extracts or mammalian cells prevents both DNA replication and centrosome duplication (Coverley et al., 2002; Hinchcliffe et al., 1999; Lacey et al., 1999; Matsumoto et al., 1999) . In Xenopus egg extracts and certain mammalian cell lines, prolonged S-phase arrest allows multiple rounds of centrosome reduplication to occur, but only when Cdk2 is active (Balczon et al., 1995; Hinchcliffe et al., 1999; Lacey et al., 1999; Matsumoto et al., 1999) . A crucial role for Cdk2 in this process has been supported by the identification of specific substrates directly involved in centrosome duplication, such as nucleophosmin (also known as B23) and CP110 (Chen et al., 2002; Okuda et al., 2000; Tokuyama et al., 2001) .
Although nearly all centrosome duplication studies have investigated the regulatory role of Cdk2 coupled to cyclin E, recent studies suggest the involvement of other cyclin-Cdk complexes. Indeed, knockout mice lacking Cdk2 or either cyclins E1 or E2 are viable, and fibroblasts isolated from cyclin E double-knockout embryos show no mitotic defects when allowed to cycle continuously (Berthet et al., 2003; Geng et al., 2003; Ortega et al., 2003; Parisi et al., 2003) . Thus, it appears that another Cdk2 activator, presumably cyclin A, can fulfill all essential cyclin E functions. A recent study confirmed this hypothesis by demonstrating that ablation of both cyclin E and cyclin A prevents cell division (Kalaszczynska et al., 2009) .
Previously, our laboratory identified a 20 amino acid domain in cyclin E as a modular centrosomal localization sequence (CLS) necessary for the centrosomal localization of cyclin E. We showed that expression of the CLS domain displaces both endogenous cyclin E and cyclin A from centrosomes, leading to cell-cycle arrest (Matsumoto and Maller, 2004) . Using a bacterial two-hybrid screen of a HeLa cDNA library, we showed that direct interaction of cyclin E with the DNA replication factor MCM5 is dependent on an intact CLS but independent of Cdk2 binding (Ferguson and Maller, 2008) . Furthermore, this interaction recruits MCM5 to centrosomes and expression of MCM5 inhibits centrosome amplification in S-phase-arrested CHO cells. Recently, we reported the characterization of the cyclin A CLS, which has many structural and biochemical features in common with the cyclin E CLS and is also crucial for cell-cycle progression (Pascreau et al., 2010) . We were therefore interested in determining whether cyclin A has a role in preventing centrosome reduplication.
Here, we show that cyclin A directly binds MCM5 and recruits it to centrosomes. More importantly, although the CLS of cyclin A The cyclin A centrosomal localization sequence recruits MCM5 and Orc1 to regulate centrosome reduplication resides in a different region of the cyclin molecule than cyclin E, we demonstrate that interaction between cyclin A and MCM5 still depends on an intact CLS and is independent of Cdk binding. Furthermore, MCM5 interaction with cyclin A or cyclin E, and inhibition of centrosome reduplication does not require binding to other MCM family members. It was recently reported that Orc1, an essential component in DNA replication licensing, is also recruited to centrosomes through interaction with cyclins A and E, and represses centrosome amplification (Hemerly et al., 2009) . We report that, like MCM5, interaction between cyclin A and Orc1 is dependent on an intact CLS and independent of Cdk2. These studies suggest that, in a normal cell cycle, cyclin A can prolong inhibition of centrosome reduplication throughout S phase and G2 by CLS-dependent centrosomal recruitment of MCM5 and Orc1.
Results
Immunoprecipitates of endogenous cyclin A from asynchronous HeLa cells readily co-precipitated MCM5, with no significant binding to an IgG control (Fig. 1A) . To confirm whether MCM5 directly binds cyclin A, GST or GST-tagged cyclin A was purified from baculovirus-infected Sf9 cells and incubated with [
35 S]-methionine-labeled MCM5 protein. The GST pulldown was separated by SDS-PAGE and analyzed by autoradiography. GSTcyclin A displayed significant binding to MCM5 compared with GST alone (Fig. 1B) . Altogether, these data indicate that cyclin A directly interacts with MCM5 in vivo.
Because interaction between MCM5 and cyclin E is dependent on a wild-type CLS but independent of Cdk2 (Ferguson and Maller, 2008) , we sought to determine whether interaction with cyclin A has the same requirements. Recent work from this laboratory showed that amino acids 201-255 of cyclin A are sufficient for centrosomal localization and that this cyclin A CLS resides in a different region of the cyclin molecule compared with cyclin E (Pascreau et al., 2010) . To identify the region of cyclin A responsible for MCM5 binding, CHO-K1 cells were transiently co-transfected with a construct encoding full-length, wild-type MCM5 and various 6-Myc-tagged constructs of cyclin A (Fig. 2A) . After transfection, CHO cell lysates were subjected to Myc immunoprecipitation and analyzed for MCM5 binding by immunoblotting. Initial analysis of two fragments of cyclin A, the N-terminal domain (amino acids 1-200) and the C-terminal domain (amino acids 201-432), demonstrated that MCM5 binding could be fully attributed to the C-terminal half of the protein, which contains the cyclin box and includes the CLS (Fig. 2B ). Further subdivision of the C-terminus of cyclin A showed that two fragments of cyclin A containing the CLS, amino acids 201-255 and amino acids 201-301, clearly bound MCM5, whereas two fragments that do not contain the CLS, amino acids 256-301 and amino acids 302-432, showed no significant MCM5 binding (Fig. 2C) . It is important to note that the two cyclin A fragments comprising amino acids 201-255 and 201-301 have previously been shown to not bind Cdks (Pascreau et al., 2010) , indicating that both centrosomal localization and MCM5 binding are Cdk-independent properties of cyclin A. It was previously reported that mutation to arginine of four conserved surface residues within the cyclin A CLS, I213, E220, E224 and K226 (IEEK-R), disrupts localization to centrosomes (Pascreau et al., 2010) . A cyclin A CLS construct containing these mutations was subjected to immunoprecipitation to determine whether MCM5 binding is likewise disrupted (Fig. 2D ). Whereas the CLScontaining fragment comprising amino acids 201-301 displayed significant MCM5 binding, mutation of these four conserved residues dramatically decreased MCM5 association. These data indicate that the CLS of cyclin A is an essential domain for binding of MCM5 and that this interaction is independent of Cdk binding.
The CLS domain of cyclin A includes within it the conserved MRAIL hydrophobic patch that is involved in substrate recognition and the binding of p27 Kip1 . Mutation of three residues in the patch, M210, L214 and W217, to alanine (MLW-A) has been reported to impair binding of substrates and p27
Kip1 without affecting binding to Cdk2 (Furstenthal et al., 2001; Russo et al., 1996; Schulman et al., 1998) . Therefore, we analyzed the ability of this mutant to bind MCM5. Surprisingly, MCM5 bound the MLW-A mutant of cyclin A to the same extent as the wild-type protein (Fig. 2D) .
Previous evidence indicates that the cyclin E CLS interacts with a specific domain of MCM5 (amino acids 533-569) that is distinct from the domains involved in DNA replication (Ferguson and Maller, 2008) . The two-hybrid screen that identified the interaction of the cyclin E CLS and MCM5 resulted in isolation of multiple partial cDNA constructs encoding MCM5. Alignment of these sequences revealed a minimal 74 amino acid region of MCM5, amino acids 496-569, shared among all interacting constructs. It was important to determine the domain of MCM5 that mediates interaction with cyclin A. In an in vitro GST pulldown assay, the C-terminus of MCM5 (amino acids 496-734) and the minimal 74-residue fragment (amino acids 496-569) specifically bound to cyclin A (Fig. 3) . The 74 amino acid fragment of MCM5 was then subdivided into two equal segments, tagged with GFP and analyzed in another GST pulldown assay. Whereas neither GFP alone nor GFP-MCM5 amino acids 496-532 displayed any appreciable binding to cyclin A, GFP-MCM5 amino acids 533-569 specifically bound cyclin A, indicating that the same region of MCM5 mediates binding to both cyclin E and cyclin A.
Centrosomal localization of MCM5 dependent on cyclin E binding inhibits centrosome reduplication in S-phase-arrested CHO cells. We have proposed that the recruitment of MCM5 to centrosomes functions as a potential feedback mechanism to prevent cells from reduplicating centrosomes after initiation of DNA synthesis (Ferguson and Maller, 2008) . It is evident that sustaining this inhibition throughout S phase and G2 after cyclin E levels decline would be crucial for ensuring the once-and-only-once duplication of centrosomes that is essential for maintaining genomic stability. Expression of the CLS of either cyclin A or cyclin E displaces both endogenous cyclins, indicating homologous functionality (Matsumoto and Maller, 2004; Pascreau et al., 2010) . Displacement of these cyclins also results in the displacement of endogenous MCM5, which can be restored by exogenous cyclin E that is centrosomally localized by means of a different targeting motif (Ferguson and Maller, 2008 ) -the pericentrin-AKAP450 centrosomal targeting (PACT) domain (Gillingham and Munro, 2000) . Fusion of the PACT domain to cyclin A causes centrosomal localization even in cells expressing the CLS domain (Pascreau et al., 2010) . It was first determined whether expression of the CLS of cyclin A displaces endogenous MCM5 from centrosomes. Cells were transiently transfected with GFP-tagged cyclin A amino acids 1-200, the GFP-tagged wild-type cyclin A CLS or the GFP-tagged IEEK-R mutant CLS, followed by immunofluorescent analysis of endogenous MCM5 localization (Fig. 4A,B) . Whereas expression of GFP-tagged cyclin A 1-200 or the GFP-tagged IEEK-R mutant CLS did not alter MCM5 localization, expression of the wild-type GFP-tagged CLS resulted in the striking displacement of MCM5 from centrosomes. Cells were then co-transfected with the wildtype GFP-tagged CLS and either PACT-fused 6-Myc-tagged fulllength cyclin A or the PACT-fused 6-Myc-tagged amino acids 1-200 of cyclin A, a fragment that does not contain the CLS and is unable to bind MCM5 (Fig. 2B) . Analysis of endogenous MCM5 localization in cells coexpressing GFP-tagged CLS and these constructs revealed that PACT-fused full-length cyclin A restores MCM5 localization to centrosomes, whereas the fragment unable to bind MCM5 does not. This indicates that cyclin A, like cyclin E, directly recruits MCM5 to centrosomes and suggests that MCM5-mediated inhibition of centrosome reduplication persists throughout interphase.
We next sought to determine whether MCM5-mediated inhibition of centrosome reduplication requires binding to other MCM family members. Previous evidence indicates that expression of MCM5 but not MCM2, a related member of the MCM family, inhibits centrosome reduplication in S-phase-arrested CHO cells (Ferguson and Maller, 2008) , suggesting a function specific to MCM5. Binding of MCM5 to other MCM family members is required for DNA replication functions of MCM5. However, the necessity for MCM5 to bind other family members in order to inhibit centrosome reduplication has not been determined.
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DNA replication factors and cyclin A interaction In Saccharomyces cerevisiae, mutation of highly conserved cysteine residue 183 to tyrosine (C183Y) in MCM5 disrupts binding to family members (Dalton and Hopwood, 1997) . The equivalent cysteine residue in human MCM5, C172, was therefore mutated to tyrosine (C172Y) and examined for binding to MCM3. Multiple studies show that MCM5 and MCM3 exist as a tightly associated dimer that can easily be isolated from other MCMs (Bochman et al., 2008; DaFonseca et al., 2001) . Therefore, binding to MCM3 reflects binding to all family members. Either wild-type HA-tagged MCM5 or HA-tagged MCM5 C172Y was transiently transfected into CHO cells, immunoprecipitated with an antibody to HA and analyzed by immunoblotting (Fig. 5A) . Whereas wildtype MCM5 clearly co-immunoprecipitated MCM3, no detectable MCM3 was associated with MCM5 C172Y, indicating a loss of binding to family members. To determine whether mutation of C172 had any effect on cyclin binding to MCM5, radiolabeled MCM5 C172Y was incubated with GST-cyclin A and GST-cyclin E. The resultant pulldown indicates that the MCM5 C172Y mutant binds efficiently to both cyclins (Fig. 5B) . The potential for centrosomal localization of this MCM5 mutant was then examined by immunostaining with antibodies to HA and g-tubulin (Fig. 5C) . Nearly all cells expressing HA-tagged MCM5 C172Y showed colocalization with g-tubulin, indicating that this protein still localizes to centrosomes.
To determine whether this MCM5 mutant inhibits centrosome reduplication, we analyzed centrosome duplication in hydroxyurea (HU)-arrested CHO-K1 cells expressing either HA-tagged wildtype MCM5 or HA-tagged MCM5 C172Y. After 48 hours of Sphase arrest, control cells contained an average of seven g-tubulin foci, whereas cells expressing either HA-tagged wild-type MCM5 or HA-tagged MCM5 C172Y contained an average of only four (Fig. 5D ). These data show that MCM5-mediated inhibition of centrosome reduplication does not require the formation of a heterohexameric complex with the other MCM family members.
During the course of these studies, it was reported that cyclin A also directly binds Orc1, an essential component of the prereplication complex. It was suggested that this interaction supports Orc1 localization to centrosomes and inhibits centrosome amplification (Hemerly et al., 2009 ). We therefore sought to determine whether the region of cyclin A containing the CLS that mediates MCM5 binding is also essential for Orc1 association. Myc immunoprecipitates of the same cyclin A constructs described in Fig. 2 clearly demonstrated that binding of Orc1 is mediated by the C-terminal cyclin-box-containing region, amino acids 201-432, of cyclin A (Fig. 6A) . Further analysis showed that the CLS region of cyclin A, amino acids 201-255, mediates interaction with Orc1 (Fig. 6B) . Moreover, like the association of cyclin A with MCM5, mutation of CLS surface residues (IEEK-R), but not the MRAIL hydrophobic patch subdomain within the CLS (MLW-A), disrupted the interaction of Orc1 with cyclin A (Fig. 6C) .
Discussion
During interphase of the cell cycle, Cdk2 is positively regulated through association with either cyclin E or cyclin A. These cyclins have different functions during the cell cycle, with cyclin E regulating the G1-S transition, and cyclin A controlling late Sphase progression and the G2-M transition. However, the recent isolation of cyclin E-null mouse embryonic fibroblasts that undergo continuous normal mitotic cycles indicates that a certain redundancy exists between these cyclins (Geng et al., 2003) . Presumably, cyclin A coupled to Cdk2 can readily compensate for the loss of cyclin E and promote the G1-S transition. Similarly, DNA synthesis in Xenopus egg extracts can be supported by Cdk2 binding to either cyclin E or cyclin A (Strausfeld et al., 1996; Woo and Poon, 2003) .
We recently identified a modular domain encompassing amino acids 201-255 of cyclin A as a CLS motif responsible for centrosomal localization. Although the cyclin A CLS resides in a different molecular region than the cyclin E CLS, they are structurally very similar and also functionally homologous, as expression of either displaces endogenous cyclins A and E from centrosomes and inhibits S-phase progression (Pascreau et al., 2010) . Here, we advance previous findings of CLS-dependent, direct interaction between MCM5 and cyclin E to show that cyclin A also directly binds MCM5 in a CLS-dependent, Cdk-independent manner and that this interaction recruits MCM5 to centrosomes.
Significantly, the cyclin A CLS includes the highly conserved hydrophobic patch containing the MRAIL amino acid sequence. This region has been reported to mediate binding of the cyclin-Cdk complex to substrates and regulatory proteins that contain a complementary hydrophobic sequence known as the K/RXL or Cy motif (Schulman et al., 1998; Takeda et al., 2001; Wilmes et al., 2004) . It was previously reported that the binding of Orc1 to cyclin A is dependent on a K/RXL motif within Orc1 (Hemerly et al., 2009) . Although these results suggest that the interaction of cyclin A with Orc1 might be MRAIL dependent, our studies with the MLW-A hydrophobic patch mutant of the cyclin A CLS indicate that a wild-type MRAIL sequence is not required. Instead, mutation of four downstream residues essential for CLS function results in reduced binding of both Orc1 and MCM5 to cyclin A. The ability of a CLS with hydrophobic patch mutations to still bind Orc1 and MCM5 probably reflects the contributions of other subdomains within the CLS to mediate binding.
Interestingly, although it has been reported that interaction between cyclin E and Orc1 is indirect (Hemerly et al., 2009) , we previously described a direct interaction between cyclin E and MCM5 (Ferguson and Maller, 2008) . Using MCM5 truncation mutants, we have shown here that the same region of MCM5 mediates direct binding to both cyclins A and E. Additionally, this region, amino acids 533-569, does not contain a K/RXL motif, indicating that the mechanism of binding to MCM5 does not require a wild-type hydrophobic patch; this was confirmed in our experiments (Fig. 2D) . Although the CLS domains of cyclin A and cyclin E reside in distinct regions of the molecules, the fact that both CLS domains have a similar sequence and three-dimensional structure and that mutation of four CLS residues disrupts binding to both MCM5 (Fig. 2) and Orc1 (Fig. 6) indicates that interaction occurs through conserved CLS mechanisms. Thus, the CLS is not only a localization motif, but also an interaction domain for specifically targeting Cdk2 complexes to centrosomes.
It was previously shown that the expression of MCM5 but not MCM2, a related MCM family member, inhibits centrosome duplication in S-phase-arrested CHO-K1 cells (Ferguson and Maller, 2008) . The work shown here suggests that recruitment of MCM5 and Orc1 to centrosomes by interaction with cyclin A contributes to inhibition of centrosome reduplication throughout late S phase and G2. Because centrosomes are still able to duplicate in cells arrested during these later interphase stages (Hanashiro et al., 2008) , it is crucial that mechanisms preventing reduplication are actively maintained. Importantly, we have shown here that MCM5-mediated inhibition of centrosome reduplication does not require binding to any other MCM proteins. Thus, MCM5 regulation of centrosome number does not require assembly of the heterohexameric MCM complex and is distinct from its role in DNA replication.
Our data show that cyclin E and cyclin A function similarly in binding MCM5 and Orc1, controlling initiation of S phase and regulating centrosome duplication. With evidence that loss of cyclin E can be readily compensated by cyclin A, we propose that cyclin A plays a central role in regulating and maintaining centrosome number throughout interphase. Additionally, these studies support an apparent trend whereby proteins involved in DNA replication have dual functions in coordinating and regulating both DNA replication and centrosome duplication (Bettencourt-Dias and Glover, 2007; Ferguson and Maller, 2008; Hemerly et al., 2009; Tachibana et al., 2005) .
Materials and Methods

Cell culture and transfection
CHO-K1 and HeLa S3 cells were grown as described previously (Ferguson and Maller, 2008) . All transfections were carried out with Lipofectamine 2000 transfection reagent (Invitrogen) according to the manufacturer's directions.
Immunoprecipitation
For endogenous cyclin A immunoprecipitation (IP), HeLa S3 cells were lysed in NP-40 lysis buffer (150 mM NaCl, 50 mM Tris pH 8.0, 1% NP-40) supplemented with 1ϫ complete protease inhibitor (Roche), 1 mM AEBSF (Sigma), and phosphatase inhibitor cocktails 1 and 2 (Sigma). Agarose protein A beads (Sigma) were incubated with either anti-cyclin A antibody (Santa Cruz, sc-751) or control rabbit IgG (Santa Cruz) for 2 hours at 4°C, followed by incubation overnight at 4°C with 1 mg of lysate protein. Immunoprecipitates were separated on 10% SDS-PAGE, transferred to PDVF membranes and immunoblotted for proteins of interest. For blotting, the following primary antibodies were used against cyclin A (Cell Signaling, BF683) and MCM5 (Abcam, 17967). Coimmunoprecipitation of Cdk2 and Cdk1 was detected with a monoclonal antibody to PSTAIR (Sigma, P7962).
For Myc IP, CHO-K1 cells were transfected with pcDNA5-FRT-Myc-tagged cyclin A constructs. Approximately 20 hours after transfection, cell lysates were incubated with either preconjugated Myc-antibody agarose beads (Santa Cruz, 9E10) or control preconjugated mouse IgG agarose beads (Santa Cruz) for 3 hours at 4°C. Immunoprecipitates were separated on 10% SDS-PAGE, transferred to nitrocellulose membranes and proteins of interest detected by immunoblot analysis. The following primary antibodies were used: Myc (Santa Cruz, 9E10-HRP conjugated); MCM5 (Abcam, 17967); and Orc1 (Bethyl).
For HA IP, HeLa S3 cells were transfected with pcDNA5-FRT-HA-tagged MCM5 constructs. Approximately 20 hours after transfection, cell lysates were incubated at 4°C with protein A agarose beads (Sigma) bound to either rabbit polyclonal antibody to HA tag (Abcam, 9110) or control normal rabbit IgG (Santa Cruz). Immunoprecipitates were separated on 10% SDS-PAGE and proteins of interest detected by immunoblot analysis with primary antibodies to MCM5 (Abcam, 17967) and MCM3 (Abcam, 60597).
GST pulldown
GST and GST-tagged human cyclin A were purified from baculovirus-infected Sf9 cells obtained from the University of Colorado Cancer Center Tissue Culture Core Facility as previously described (Ferguson and Maller, 2008) . For pulldown analysis, GST and GST-tagged cyclin A or cyclin E bound to glutathione beads were incubated overnight at 4°C in TIF buffer (20 mM Tris pH 8.0, 150 mM NaCl, 1 mM MgCl 2 , 0.1% NP-40 and 10% glycerol), with MCM5 protein produced in an in vitro transcription-translation (TNT)-coupled reaction according to the manufacturer's protocol (Promega). MCM5 protein was radiolabeled with [ 35 S]-methionine during the TNT reaction. Pulldowns were separated on a 10% SDS-PAGE. Gels were dried and exposed to Kodak Biomax MR film.
Microscopy
CHO-K1 cells were seeded onto collagen-coated glass coverslips (Iwaki, Japan) and fixed with -20°C methanol for 15 minutes. Cells were immunostained with indicated primary antibodies to MCM5 (Santa Cruz, 22780), g-tubulin (Sigma, GTU088 or Abcam, ab27076), or HA-Alexa-Fluor-488 conjugate (Molecular Probes, 16B12). The GFP signal was visualized by direct fluorescence. All primary antibody incubations were for 1 hour at room temperature, followed by secondary antibody staining. Secondary antibodies, either goat anti-rabbit or anti-mouse conjugated to Alexa-Fluor-488 or Alexa-Fluor-594 (Molecular Probes), were incubated with cells for 45 minutes at room temperature. Microscopic observations were made on a Nikon Eclipse TE300 inverted microscope with a 100ϫ oil-immersion objective (NA 1.4). Images were obtained with either a PCM2000 confocal laser scan or an air-cooled charge-coupled device (CCD) camera (SenSys Photometrics) attached to a 0.76ϫ coupler (Diagnostic Instruments). Images and line scans measuring centrosome-associated integrated fluorescence intensity were generated using simple PCI imaging software (Compix). 
Centrosome duplication
CHO-K1 cells were placed in media containing 4 mM HU for 24 hours, followed by transient transfection of either pcDNA5-FRT-HA-tagged wild-type MCM5 or HA-tagged MCM5 C172Y. 24 hours after transfection (for a total of 48 hours HU treatment), cells were methanol fixed and processed for immunofluorescent staining. Cells were stained for centrosomes using g-tubulin (Sigma, AK-15) and HA (Molecular Probes, A-21287).
